Evidence map›Paper›PMID 42898670›Full record

ReviewFrontiers in immunology2026

The multiple sclerosis exposome: environmental determinants, immunological convergence, and the Gulf Region as a natural test case.

Eslam Shosha, Najeeb Qadi

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eslam ShoshaNeuroscience Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Najeeb QadiNeuroscience Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The multiple sclerosis (MS) exposome is widely invoked but rarely measured; grouping environmental exposures together obscures large differences in evidence quality. Much of the existing gene-environment evidence originates from genetically and environmentally homogeneous northern European cohorts, leaving open whether it generalizes elsewhere. The Gulf Cooperation Council (GCC) region is a largely untested candidate for such a test: ambient particulate concentrations there routinely exceed international guideline values, the dominant particulate sources and composition differ from those characterized in European studies, and the region's HLA-DRB1 allele distribution diverges substantially from the populations in which most gene-environment interaction evidence has been generated. Approach: This narrative review appraises exposure domains against six pre-specified criteria-design, exposure assessment, temporality, dose-response, confounding control, and gene-environment interaction-and reports effect estimates. Search strategy, selection criteria, and appraisal limitations are stated explicitly. Key findings: Inhalational exposures carry the most coherent signal. Pooled long-term particulate estimates are modest but consistent (PM Working model: Chemically diverse exposures converge toward a limited set of immunological nodes-aryl hydrocarbon receptor activation, short-chain fatty acid depletion, EBNA1/GlialCAM mimicry, and oxidative impairment of regulatory T cells-each conditioned by HLA-restricted susceptibility. Implications: We set out why the Gulf Cooperation Council region may be an informative setting for testing this model, which designs and immunological endpoints would test it, and what would falsify it.

Indexed as

Environmental ExposureExposomeMultiple SclerosisGene-Environment InteractionHLA-DRB1 ChainsHumansParticulate MatterHLA-DRB1 ChainsParticulate Matterair pollutionenvironmental risk factorsexposomegene–environment interactiongulf cooperation councilheavy metalsmultiple sclerosisorganic solvents

Identifiers

PMID42898670
PMCPMC13678491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.